The potential resource of heterogeneity of the summarized proportion of NAFLD patients and NASH patients with normal ALT value may contributed by the genetic factors and individual difference, detailed studies should be conducted to illuminate this phenomenon in the future. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.